Tci Wealth Advisors, Inc. Glycomimetics Inc Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 27, 2020	SELL	$4.03 - $6.5 $403 - $650	-100 Closed	0 $0
Q1 2019 Apr 11, 2019	SELL	$9.96 - $13.44 $996 - $1,344	-100 Reduced 50.0%	100 $1,000
Q3 2018 Nov 02, 2018	SELL	$13.7 - $17.12 $2,740 - $3,424	-200 Reduced 50.0%	200 $3,000
Q2 2018 Jul 27, 2018	BUY	$14.63 - $19.19 $1,463 - $1,919	100 Added 33.33%	400 $6,000
Q1 2018 Apr 30, 2018	BUY	$16.06 - $25.35 $4,818 - $7,605	300 New	300 $5,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.8M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.